Dr. Maurie Markman comments on a study published in the Journal of Clinical Oncology describing the use of the EML4-ALK fusion oncogene to predict response to EGFR therapy in patients with NSCLC. Medscape Genomic Medicine
Acupuncture appears to be as effective as venlafaxine in reducing vasomotor symptoms, and might provide additional and longer-term benefits without adverse effects. Medscape Medical News
This lively Spotlight focuses on recent advances in the treatment of renal cell cancer, with emphasis on current trials and future directions that may result in improved therapies for patients. Medscape Hematology-Oncology
Clinical and basic science advances have improved outcomes for patients with nervous system cancers, a new series of articles show. Medscape Medical News
